To Evaluate the Safety, Tolerability, and Pharmacokinetics of Inavolisib Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Solid Tumor
Interventions: DRUG: Inavolisib|DRUG: Fulvestrant|DRUG: Letrozole|DRUG: Palbociclib|DRUG: Metformin|DRUG: Trastuzumab|DRUG: Pertuzumab
Sponsor: Genentech, Inc.